copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Careers | Pfizer We’ve transformed growth and development at Pfizer to ensure that everyone can follow a path to their dream career, whether that’s climbing a traditional ladder or “zig-zagging” their way to a new role
Pfizer’s Solid Q3 2025 Performance These reports are available at pfizer com and the SEC's website Also reference Pfizer’s third quarter 2025 earnings release for additional information regarding our financial guidance details and assumptions
Pfizer Pipeline Visit www pfizer com pipeline, Pfizer’s online database where you can learn more about our portfolio of new medicines and find out more about our Research and Development efforts around the world
Pfizer Inc. - Investor Relations We're elevating our breakthroughs in a bold new way on Pfizer com Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development!
Pfizer Declares Fourth-Quarter 2025 Dividend NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc (NYSE: PFE) today announced that its board of directors declared a $0 43 fourth-quarter 2025 dividend on the company’s common stock, payable December 1, 2025, to holders of the Common Stock of record at the close of business on November 7, 2025
Bothell, WA - Pfizer Cambridge, Massachusetts Located in Kendall Square, our Cambridge site interlaces Pfizer’s R D capability with the densest biomedical community in the world
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA . . . This release contains forward-looking information about Pfizer Oncology and PADCEV® (enfortumab vedotin-ejfv) in combination with pembrolizumab in patients with previously untreated locally advanced or metastatic urothelial cancer, including their potential benefits, that involves substantial risks and uncertainties that could cause actual
Pfizer + Seagen At Pfizer, we’ve shown how we can move with urgency to deliver breakthroughs that change patients’ lives And now, we’re making significant investments to tackle cancer – one of the biggest health challenges of our lifetime